Is It Time for Stand-Alone HPV Testing?
Now that stand-alone HPV tests have been approved, is it worth changing cervical cancer screening recommendations? Juan Felix, MD, weighs in.
Cervical Treatments Don't Hinder Fertility
Treatments to remove precancerous cervical lesions don't seem to affect a woman's ability to become pregnant, new research found.
HPV Vaccine Not Linked to Unsafe Sex
Adolescent girls who receive the HPV vaccine are no more likely than unvaccinated girls to participate in risky sexual behavior.
Urine Test Works for HPV Screening
Urine tests effectively screen for HPV, but more data is needed to determine whether they can correctly diagnose cervical disease.
Cervical Cancer Screening Tests Continue to Evolve
Be it Pap tests, HPV tests, or both, cervical cancer screening is important. This article explores screening paradigms and offers a glimpse of what's to come.
FDA Update: Bevacizumab Is Approved for Cervical Cancer
The FDA has approved bevacizumab (Avastin) for treating persistent, recurrent, or metastatic cervical cancer after studies show gains in overall survival.
Already Had Sex? The HPV Vaccine Still Has Value
The optimal time to get the HPV vaccine is before a first sexual encounter. But getting the vaccine after still offers significant protection against cervical dysplasia.
Pelvic Exams Have Value: Does Skipping Them Put Women at Risk?
The American College of Physicians (ACP) recommends against pelvic exams in asymptomatic, nonpregnant, adult women. Some say this is faulty logic. What say you?
Back to Basics: The Well-Woman Visit
Don’t let time constraints and large patient loads prevent you from providing a thorough well-woman visit. Are you covering all the bases?
Evidence Mounts for Effectiveness of National HPV Vaccine Program
Three doses of the quadrivalent HPV vaccine was more effective in preventing high-grade cervical abnormalities than other types and more effective in younger women.